Test Bank- Clayton’s Basic Pharmacology for Nurses, 19th Edition ( Author : Bruce D. Clayton, 2022), All Chapters || Latest Edition

TestBank For Clayton’sBasic Pharmacology for Nurses
xn nxnx nxnx nxxn nxnx nxnx nxnx




19th EditionBy Michelle J. Willihnganz, Samuel L.
nxnx nxnx xn nxnx nxnx nxnx nxnx nx nx




Gurevitz, Bruce Clayton Complete Latest Test Bank 100%
nxnx nxnx nxnx nx nx nx nx nxnx nx nx nxnx




Verified Answers
nxnx nx nx

,Chapter A01: ADrug ADefinitions, AStandards, Aand AInformation ASources
nx nx nx nx nxnx nx nx nxnx nxnx nx nx




AWillihnganz: AClayton’s ABasic APharmacology Afor ANurses, A19th AEdition
nx nx nxnx nxnx nxnx nxnx nxnx nxnx nxnx




MULTIPLE
ACHOICE
nxnx




1. Which Aname Aidentifies AaAdrugAlisted AbyAthe AUS nxnx nxnx nxnx nxnx nx n xn x x
n nxnx




Food AandADrug AAdministrationA(FDA)?
nxnx A nxnx nx nxnx xx
n




a. Brand
b. Nonproprietary
c. Official
d. Trademark
ANS: AC nxnx




The A official A name A is A the A name A under A which
n x n x n x n x n x n x n x n x n x n x n x n x n x n x




nA a A drug A is A listedA
x n x by Athe AFDA. AThe Abrand Aname, Aor
n x n x n x n x n x n x nx nxn x nxnx nxnx nxnx nx nx nxnx




Atrademark, Ais Athe Aname Agiven Ato Aa Adrug Aby Aits
nxnx n xnx nxnx nxnx nx nx nx nx nxnx nxn x nx nx nxn x




Amanufacturer. AThe Anonproprietary, Aor Ageneric, Aname Ais
nxnx nxnx nxnx nx nx n xn x nx n x nx nx




Aprovided
nxnx Aby Athe AUnited AStates AAdopted ANames n xn x nxn x nxnx nx n x nx n x n xn x




DIF:
nxnx
Cognitive ALevel:AKnowledge
ACouncil. REF: Ap.A9 nxnx nxx nxnx x
n




OBJ: A1NAT: ANCLEX AClient ANeeds ACategory: ASafe, AEffective nxnx nxnx nxnx nxnx nxnx nxnx nxnx




nxnxA CareAEnvironment ATOP: A Nursing AProcess AStep: AAssessment
nx nxnx n x n x nxnx nxnx nxnx




CON:
nx nx APatient AEducation nxnx




2. Which Asource Acontains Ainformation Aspecific Ato Anutritionalsupplements? nxnx nx nx nxnx nxnx n xn x n xnx




a. USP ADictionary Aof AUSAN A & AInternational ADrugANames nxnx nxnx nxnx nxnx nxnx nx nx x
n




b. Natural AMedicines AComprehensiveADatabase nxnx nxnx x
n




c. United AStates APharmacopoeia/National AFormulary A(USPNF) n x nx nx n x nx nx nxnx




d. Drug AInteractionAFacts nx nx nx




ANS: AC nxnx




United AStates APharmacopoeia/National AFormulary Acontains Ainformation Aspecific Ato nxnx nxnx nxnx nxnx nxnx nxnx nxn x




AnutritionalA
nxnx supplements. AUSP ADictionary Aof AUSAN A& AInternational ADrug ANames Ais Aa nx nxn x nxnx nxnx nxnx nxnx nxnx nxnx nxnx nxnx nxnx




Acompilation Aof Adrug Anames, Apronunciation Aguide, Aand Apossible Afuture AFDA Aapproved
nxnx nxnx nxnx n xn x nxnx nxn x nxnx nxnx nxnx nx nx n xnx




Adrugs; Ait Adoes Anot Ainclude Anutritional Asupplements. ANatural AMedicines AComprehensive
nxnx nxn x nxnx nxnx nx nx n xn x nxnx n xn x nxnx nxnx




ADatabase Acontains
nxnx nxnx




evidence-based Ainformation Aon Aherbal Amedicines Aand Aherbal Acombination Aproducts; Ait nxnx nxnx nxnx nxnx nxnx n xnx nxn x nxnx nxnx




Adoes AnotA
nxnx include Ainformation Aspecific Ato Anutritional Asupplements. ADrug AInteraction
n xnx nx nxnx nxnx nxnx n xnx nxnx nxnx nxnx




AFacts Acontains Acomprehensive Ainformation Aon Adrug Ainteraction Afacts; Ait Adoes Anot
nxnx nxnx nxn x nxnx nxnx nxnx nxnx nxn x nxnx nxnx nxn x




Ainclude Anutritional Asupplements.
nxnx n xnx nx nx




DIF: Cognitive ALevel:AKnowledge REF: A p. A4 OBJ: nxnx nxx n x n x nxnx




A3ANAT: ANCLEX AClient ANeeds ACategory: APhysiologicalAIntegrity
nxnx x
n nx nx nxn x nxn x nxn x nxn x x
n




TOP: A Nursing AProcess AStep: AAssessment CON: ANutrition A| APatientAEducation
n x n x nxnx n x nx nxnx nx nx nxnx nxnx x
n




3. WhichAdrugAreference Acontains AdrugAmonographs Athat Adescribe Aall Adrugs AinAa Atherapeutic Aclass?
nx nx nxnx nxnx x
n nxnx nxnx nxnx nxnx nxnx x
n nxnx nxnx




a. Drug AFacts AandAComparisons nxnx nxnx nx

, b. Drug AInteractionAFacts nx nx nx




c. Handbook Aon AInjectableADrugs nxnx nxnx nx




d. Martindale—The AComplete ADrugAReference nxnx nx nx x
n




ANS: AA nxnx




Drug AFacts Aand AComparisons Acontains Adrug Amonographs Athat Adescribe Aall
nxnx nxnx nxnx nxnx nxnx nxnx nxnx nxnx nx nx




Adrugs Ain Aa Atherapeutic Aclass. AMonographs Aare Aformatted Aas Atables Ato Aallow
nxnx nx nx nxnx n xn x nxn x nxnx n xnx nx nx nxn x nx nx n xnx nxn x




Acomparison Aof AsimilarAproducts, Abrand Anames, Amanufacturers, Acost Aindices,
nxnx nxnx nxnx nx nxnx nx nx nxnx nx nx nx nx




Aand Aavailable Adosage Aforms AOnline Aversion Ais Aavailable.
nxnx n xnx nx nx nxnx n x nx nxnx nxnx nxnx




DIF: CognitiveALevel:AKnowledge REF: Ap. A4 ATableA1.2 nx nx nxnx nxnx nxnx x
n




OBJ: A A A 3 NAT: ANCLEX AClient ANeedsACategory: APhysiological AIntegrity
nxnx nxnx n x n x nxnx nxnx nxnx xx
n nxnx nxnx




TOP: A Nursing AProcess AStep: AAssessment
n x CON: ASafety A| APatient AEducation A| AClinicalAJudgment
n x nxnx nxn x nxnx nx nx nxnx nxnx nxnx nxnx nxnx x
n




4. WhichAdrugAreference Acontains Amonographs Aabout A virtuallyAeveryAsingle-entitydrug
nx nx nxnx nxnx nxnx n x n x x
n x
n




availableAin Athe AUnited AStates Aand Adescribes Atherapeutic Auses Aof Adrugs, Aincluding
nxnx A nx nxnx nxnx nxnx nx nx nxnx n xnx nxnx nxnx nxnx nxnx




approved Aand Aunapproved Auses?
nxnx A nxn x n xn x nxnx




a. Martindale: AThe AComplete ADrugAReference nxn x nxnx nx nx x
n




b. AHFS ADrugAInformation nxnx nx




c. DrugAReference nx




d. Drug AFacts AandAComparisons nxnx nxnx nx




ANS: AB nxnx




AHFS ADrug AInformation Acontains Amonographs Aabout Avirtually Aevery Asingle-entity Adrug
nxnx nx nx nxnx n xnx nxnx nxnx nx nx nx nx nx nx




Aavailable Ain Athe AUnited AStates Aand Adescribes Atherapeutic Auses Aof Adrugs, Aincluding
nx nx nxn x nxnx nxnx nxnx nxn x nx nx nx nx nxnx nxnx nxnx nx nx




Aapproved AandA
nxnx unapproved Auses. nxn x nx nxnx




DIF: CognitiveALevel:AKnowledge REF: Ap. A4 ATableA1.2 nx nx nxnx nxnx nxnx x
n




OBJ: A A A 3 NAT: ANCLEX AClient ANeeds ACategory: APhysiologicalAIntegrity
nxnx nxnx n x n x nxnx nxnx nxnx nxnx nxnx x
n




TOP: A Nursing AProcess AStep: APlanning CON: ASafety A| APatient AEducation A| AClinicalAJudgment
n x n x nxnx nxnx nxnx nxnx nxnx nxnx nxnx nxn x nxnx x
n




5. Which Aonline Adrug Areference Amakes Aavailable Ato Ahealthcare Aproviders Aand Athe
nxnx nxnx nxnx nxnx nxn x nxnx nxnx nxnx nx nx nxnx




public Aa Astandard,Acomprehensive, Aup-to-dateAlookAupAandAdownloadable Aresource
nxnx A nxn x n xn x nx nxnx x
n x
n x
n x
n nxnx




Aabout Amedicines?
nxnx nxnx




a. American ADrugAIndex nxnx nx




b. American AHospitalAFormulary nxnx nx




c. DailyMed
d. DrugAReference nx




ANS: AC nxnx




DailyMed Amakes Aavailable Ato Ahealthcare Aproviders Aand Athe Apublic Aa Astandard, nxnx nxn x nxnx nxn x nxnx nxnx nxn x nxn x nxnx nx nx




Acomprehensive,Aup-to-date Alook Aup Aand Adownloadable Aresource Aabout Amedicines. AThe
nxnx nx nxnx n xnx n xnx nxnx nx nx nxnx nxnx nxnx




AAmerican ADrug AIndex AisA
nxnx not Aappropriate Afor Apatient Ause. AThe AAmerican AHospital nxnx nxnx nxnx nx nxn x nx nx nxnx nxnx nxnx nxnx nxnx




AFormulary Ais Anot Aappropriate Afor Apatient Ause. AThe Adrug Areference Ais Anot Aappropriate
nxnx nxnx nxnx nxnx nxnx n xn x nxnx nxnx nxnx nxnx nxnx nxnx nxn x




Afor Apatient Ause.
nx nx nxnx nxnx




DIF: Cognitive ALevel:AKnowledge REF: A A Ap. A3 A|p. A4 OBJ: nxnx nxx nxnx nxnx nx nx nx nx nxnx nxnx




A3ANAT: ANCLEX AClient ANeeds ACategory: APhysiologicalAIntegrity
nxnx x
n nx nx nxn x nxn x nxn x nxn x x
n




TOP: ANursing AProcess AStep: AImplementation
nxnx nxnx nxnx nxnx




CON: ASafety A| APatient AEducation A| AClinical AJudgment
nxnx nxnx nxnx nxnx nxnx nxnx nxnx




6. Which Alegislation Aauthorizes Athe AFDAAto Adetermine Athe AsafetyAofAaAdrugAbefore Aits Amarketing?
nxnx nxnx nxnx nxnx x
n n xn x nxnx nxnx x
n x
n x
n x
n nxnx nxnx




a. Federal AFood, ADrug, Aand ACosmetic AActA(1938) nxnx nxnx nxnx nx nx n xn x x
n




b. Durham AHumphrey AAmendmentA(1952) nxn x nxnx x
n

, c. Controlled ASubstances AActA(1970) nxnx n x nx x
n




d. Kefauver AHarris ADrug AAmendmentA(1962) nxnx nxnx nxn x x
n




ANS: AA nxnx




The AFederal AFood, ADrug, Aand ACosmetic AAct Aof A1938 Aauthorized Athe AFDA Ato
nxnx n xnx nxnx nx nx nxnx nxn x n xnx nxnx n xnx nxnx n xnx nx nx




Adetermine Athe Asafety Aof Aall Adrugs Abefore Amarketing. ALater Aamendments Aand Aacts
nxnx nxnx nx nx nxn x nxnx nxnx n xnx nxnx nxnx n xnx nxnx nx nx




Ahelped Atighten AFDA Acontrol Aand Aensure Adrug Asafety. AThe ADurham AHumphrey
nxnx nxnx nx nx nxn x n xn x nxnx nxnx nxnx nxn x n xnx nxn x




AAmendment Adefines Athe Akinds Aof Adrugs Athat Acannot Abe Aused Asafely Awithout Amedical
nxnx n xnx nxn x nxnx nx nx n xnx n xnx n xn x nxnx nxn x nx nx nxnx nxnx




Asupervision Aand Arestricts Atheir Asale Ato Aprescription Aby Aa Alicensed Apractitioner. AThe
nxnx nxn x n xnx nxnx nxn x n xnx nxn x nxnx nxnx nx n x nxnx nxnx




AControlled ASubstances AAct Aaddresses Aonly Acontrolled Asubstances AandAtheir
nxnx nxnx nxn x nxnx nxnx nxnx nxnx nxnx x
n




Acategorization. AThe AKefauver AHarris ADrug AAmendment Aensures Adrug Aefficacy Aand
nxnx nxnx nxnx nxn x nxnx nx nx nxnx nx nx n xnx nxnx




AgreaterAdrug Asafety. ADrug Amanufacturers Aare Arequired Ato Aprove Ato Athe AFDA Athe
nxnx nx nx nx nxnx nx nx nxn x nxn x nxn x nxnx n xnx nxnx nxnx nxnx




Aeffectiveness Aof Atheir Aproducts Abefore Amarketing Athem.
nxnx nxnx nxn x n xn x nxnx nxnx nxnx




DIF: CognitiveALevel:AKnowledge REF: Ap. A5 ATableAl.3 nx nx nxn x nxnx nxnx x
n




OBJ: A 5 NAT: ANCLEX AClient ANeeds ACategory: APhysiological
n x n x nxnx nxnx nxnx nxnx nxnx




AIntegrityATOP: ANursing AProcess AStep:AAssessment
nxnx nx nxnx nxnx nxn x x
n




CON: ASafety A| APatient AEducation A| AEvidence A| AHealth ACare ALaw
nxnx nxnx nxnx nxnx nxnx nxnx nxnx nxnx nxnx nxnx




7. Which Aclassification Adoes Ameperidine A(Demerol) AfallAunder?
nx nx nxnx n x nx nx nx nxnx x
n




a. I
b. II
c. III
d. IV
ANS: AB nxnx




Meperidine A(Demerol) Ais Aa ASchedule AII Adrug; Ait Ahas Aa Ahigh Apotential Afor Aabuse Aand nx nx nxnx nxnx n xnx nxnx n xnx nx nx nxnx nxnx nx nx nxnx nxnx nxnx nxnx




Amay Alead Ato Asevere Apsychological Aand Aphysical Adependence. ASchedule AI Adrugs Ahave
nxnx nx nx nxnx n xn x nxn x nxnx nxnx nxnx nx nx nxnx nxnx nxnx




Ahigh Apotential Afor AabuseA
nxnx and Ano Arecognized Amedical Ause. ASchedule AIII Adrugs Ahave
nxnx nxnx nxn x nx nx nx nx nx nxnx nxnx nxn x nxnx nxnx nxnx




Asome Apotential Afor Aabuse. AUse Amay Alead Ato Alow Ato Amoderate Aphysical Adependence Aor
nxnx nxn x nxnx n xnx nxnx nxnx nx n x nxnx nxnx nxnx nxnx nxnx nxnx nxnx




Ahigh Apsychological Adependence. ASchedule AIV Adrugs Ahave Alow Apotential Afor Aabuse.
nxnx nxnx nxn x nxnx nx nx n x nx nxn x nxnx nxnx nxnx nxnx




AUse Amay Alead Ato Alimited Aphysical Aor Apsychological Adependence.
nxnx nxnx nxnx nxn x nxnx nxnx nxnx nxnx n x nx




DIF: Cognitive ALevel:AKnowledge REF: A p. A10 OBJ: nxnx nxx n x n x n xnx




A2ANAT: ANCLEX AClient ANeeds ACategory: ASafe, AEffective ACare
nxnx x
n nxnx nxnx nxnx nxnx nxnx nxnx nxnx




AEnvironment
nxnx




TOP: A Nursing AProcess AStep: AAssessment
n x CON: APatient AEducation A| AAddiction A| APain
n x nxnx nxn x nxnx nxnx nxnx nxnx nxnx nxnx nxnx




8. WhichAaction Awould Athe AFDAAtakeAto AexpediteAdrugAdevelopment A and AapprovalAforAan
nx nxnx nxnx nxnx nx x
n nxnx x
n x
n n xn x nxnx xn
nx xx
n




A
nxnx outbreakAof Asmallpox? nx nxnx




a. List Asmallpox Aas Aa Ahealth Aorphandisease. nxnx n xn x nxnx nx nx nxnx




b. Omit Athe Apreclinical Aresearchphase. nxnx nx nx n xnx




c. ExtendAtheAclinicalAresearchAphase. nx nx nx nx




d. FastAtrackAtheAinvestigationalAdrug. nx nx nx x
n




ANS: AD nxnx




Once Athe AInvestigational ANew ADrug AApplication Ahas Abeen Aapproved, Athe Adrug Acan
nx nx nx nx nxnx nxnx nxn x nxnx n xnx nxn x nxn x nxnx nxnx




Areceive Ahighest Apriority Awithin Athe Aagency, Awhich Ais Acalled Afast Atracking. AA
nxnx nx nx nxnx nx nx nxnx nxnx nxnx nxnx nx nx nxnx nxn x n xnx




Asmallpox Aoutbreak Awould Abecome Aa Apriority Aconcern Ain Athe Aworld. AOrphan Adiseases
nxnx nxnx n xnx nx n x n xnx nxnx n xnx nxnx n xnx n xnx nxnx nx nx




Aare Anot Aresearched Ain Aa Apriority Amanner. APreclinical Aresearch Ais Anot Aomitted.
nxnx nxn x nxnx nxn x nxnx nxnx n x nx nxnx nxnx nxnx nxn x nxnx




AExtending Aany Aphase Aof Athe Aresearch Awould AmeanA
nxnx aAlongerAtimeAto Adevelop AaAvaccine. nxn x n xnx nxnx nxnx nxnx nxnx n xnx x
n x
n x
n nnxx nxn x nxnx x
n




AThe AFDAAmust AensureAthat AallAphases AofAthe Apreclinical AandAclinical Aresearch Aphase Ahave
nxnx nxnx nx nxnx nx nxnx x
n nxnx x
n nxnx nx
n x
n nxnx nxnx nxnx




Abeen Acompleted Ain Aa Asafe Amanner.
nxnx nxnx nxnx nxnx n xn x nxnx




DIF: CognitiveALevel:AKnowledge nx nx REF: A A Ap. A7 nxnx nxnx nxnx nx nx OBJ: n x n x A 5